NIH-funded research U01 cooperative agreement

InterACT: Defining ARDS patient subtypes to guide future treatments

Official title: The Intermountain West-Atlantic Center (InterACT) for the APS Phenotyping Consortium

Funded at Ihc Health Services, INC. · NIH-11325740 · Data updated 2026-11-12

A national collaboration will analyze blood markers and clinical data from adults with ARDS, pneumonia, and sepsis to identify patient subtypes that might respond differently to therapies.

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionIhc Health Services, INC.
NIH-funded
Lab location1 site (Salt Lake City, UNITED STATES)
Project startMay 1, 2023
Project endApril 30, 2029
Funding year2026
Award (this year)$654,660
NIH project number5U01HL168416-04
Project IDNIH-11325740 on NIH RePORTER

Who could benefit from this research

Could help

Adults with ARDS, pneumonia, or sepsis who are cared for at participating sites and have available biomarker data.

Less likely to help

Patients without ARDS, pneumonia, or sepsis or those not treated at participating sites may not benefit.

What this research studies

InterACT brings together four sites to apply advanced statistics and machine learning to classify ARDS and related conditions into meaningful patient phenotypes. The project will use multiplex cytokine panels and clinical data, accounting for treatments patients receive, to improve phenotype accuracy. Findings will be checked in simulated trials to explore potential therapeutic implications, including tissue injury biomarkers like hyaluronan and sRAGE. The aim is to pave the way for treatment-responsive subgroups that could be targeted in future real clinical trials.

Why it matters

Potential benefit: If successful, patients with ARDS or related infections could receive more personalized therapies based on their phenotype.

How similar studies have gone: Previous phenotyping efforts have shown promise in guiding trials, but this project aims to validate and extend those approaches with new biomarkers and emulated trials.

Where this research is happening

  • Ihc Health Services, INC.
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Brown, Samuel Morris — Ihc Health Services, INC.
  • Study coordinator: Brown, Samuel Morris

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.